Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease. [electronic resource]
Producer: 20180813Description: 138-141 p. digitalISSN:- 1437-7780
- Amphotericin B -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antifungal Agents -- therapeutic use
- Castleman Disease -- drug therapy
- Cryptococcosis -- diagnosis
- Cryptococcus neoformans -- isolation & purification
- Cyclosporine -- therapeutic use
- Fluconazole -- therapeutic use
- Humans
- Immunosuppressive Agents -- adverse effects
- Male
- Middle Aged
- Prednisolone -- therapeutic use
- Risk Factors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.